Marlins check out Mike Lowell's debut

0 Comments

Thumbnail image for Mike Lowell headshot.jpgIt may be nothing more than that, but according to Clark Spencer of the Miami Herald, the Marlins were among teams in attendance to check out Mike Lowell’s exhibition debut against the Orioles on Monday.

According to Spencer, the Marlins have at least discussed the idea internally, though reacquiring the 36-year-old would likely be a backup plan. The Marlins are currently weighing if Logan Morrison or Gaby Sanchez are ready to play first base, or if Rule 5 selection Jorge Jimenez is a possibility to start at third base. If recovered from December thumb surgery, Lowell could be a reasonable alternative at third, with Jorge Cantu moving back to first.

Lowell, of course, played seven years in Florida and is the franchise’s all-time leader in home runs (143).

The Red Sox will likely have to eat the majority of Lowell’s remaining $12 million salary in any deal.
 

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
0 Comments

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.